Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade.
Saved in:
| Title: | Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade. |
|---|---|
| Authors: | Lin PH; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; Graduate Institute of Clinical Medical Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Chan JY; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Guan P; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Hong JH; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore., Lim AH; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Ng CC; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Yeong JPS; Integrative Biology for Theranostics Lab, Cancer Signaling & Therapies Programme, Institute of Molecular and Cell Biology, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Pathology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Lee JY; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Liu W; Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore, Singapore., Lim JCT; Integrative Biology for Theranostics Lab, Cancer Signaling & Therapies Programme, Institute of Molecular and Cell Biology, Singapore, Singapore., Pang ST; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Teh BT; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. |
| Source: | The Journal of pathology [J Pathol] 2024 Dec; Vol. 264 (4), pp. 371-382. Date of Electronic Publication: 2024 Oct 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39360336 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+PH%22">Lin PH</searchLink>; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; Graduate Institute of Clinical Medical Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chan+JY%22">Chan JY</searchLink>; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Guan+P%22">Guan P</searchLink>; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Hong+JH%22">Hong JH</searchLink>; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+AH%22">Lim AH</searchLink>; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+CC%22">Ng CC</searchLink>; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yeong+JPS%22">Yeong JPS</searchLink>; Integrative Biology for Theranostics Lab, Cancer Signaling & Therapies Programme, Institute of Molecular and Cell Biology, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Pathology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JCT%22">Lim JCT</searchLink>; Integrative Biology for Theranostics Lab, Cancer Signaling & Therapies Programme, Institute of Molecular and Cell Biology, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Pang+ST%22">Pang ST</searchLink>; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Teh+BT%22">Teh BT</searchLink>; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220204634%22">The Journal of pathology</searchLink> [J Pathol] 2024 Dec; Vol. 264 (4), pp. 371-382. <i>Date of Electronic Publication: </i>2024 Oct 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+And+Sons%22">John Wiley And Sons </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0204634 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9896 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223417%22">00223417 </searchLink><i>NLM ISO Abbreviation: </i>J Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39360336 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/path.6349 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 371 Titles: – TitleFull: Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin PH – PersonEntity: Name: NameFull: Chan JY – PersonEntity: Name: NameFull: Guan P – PersonEntity: Name: NameFull: Hong JH – PersonEntity: Name: NameFull: Lim AH – PersonEntity: Name: NameFull: Ng CC – PersonEntity: Name: NameFull: Yeong JPS – PersonEntity: Name: NameFull: Lee JY – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Lim JCT – PersonEntity: Name: NameFull: Pang ST – PersonEntity: Name: NameFull: Teh BT IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1096-9896 Numbering: – Type: volume Value: 264 – Type: issue Value: 4 Titles: – TitleFull: The Journal of pathology Type: main |
| ResultId | 1 |